Sun13Mar2016Thu17Mar2016New Orleans, Louisiana
Visit Absorption Systems at Booth #850
This 55th Annual Meeting and ToxExpo will future a broad range of scientific sessions and a thematic program that provides participants with a unique opportunity to deepen their knowledge in topical areas and interact with leaders in their respective disciplines. The scientific program includes Plenary Lectures and other featured sessions, Symposia, Workshops, Roundtable discussions, Informational Sessions, and a Regional Interest Session, as well as Platform and Poster Sessions. The Society anticipates that more than 6,500 toxicologists from more than 50 countries will attend. The SOT Annual Meeting also includes the ToxExpo, which is the largest exhibition dedicated to toxicology and the biomedical sciences. ToxExpo features 350 exhibitors who lead the industry in developing cutting-edge products, services, and technology to benefit the toxicology community. Exhibitors also have the opportunity to demonstrate their products and educate attendees about their services via Exhibitor-Hosted Sessions throughout the week. This meeting will be held at the Ernest N. Morial Convention Center in New Orleans.
For more information, please visit: https://www.toxicology.org/events/am/AM2016/
Visit Absorption Systems at Booth #805
Research: A Vision of Hope
Biomedical research is behind every advance in treatment for blinding conditions, behind every improvement in diagnostic methods and behind all progression in our understanding of the eye and visual processes. ARVO members are engaged in the research that brings hope to patients and their families that treatments and cures for eye disease are on the horizon. At the ARVO Annual Meeting, 11,000 researchers from around the world will come together to explore cutting-edge science, collaborations with their peers and the connections between their work and the people who will ultimately benefit from it. This meeting will be held at the Washington State Convention Center in Seattle, Washington.
For more information, please visit: http://www.arvo.org/_conferencesite/default.aspx
Mon06Jun2016Thu09Jun2016San Francisco, CA
Save the Dates: June 6-9, 2016 | Moscone Center, San Francisco, CA
The BIO International Convention returns to the birthplace of biotech, San Francisco, California for 2016! The Bay Area region continues to grow and advance biomedical innovation while continuing to offer programs and services to support new medical advances. Join the global biotech community in San Francisco and see how the everyday becomes extraordinary at BIO 2016!
Click Here for more information.
Mon27Jun2016Tue28Jun2016South San Francisco, California
Please join Absorption Systems this June 27th & 28th in South San Francisco, California!
For more information and to register, please click here.
Join Absorption Systems at CRS 2016! Visit us at Booth 707
It’s the 43rd CRS Annual Meeting & Exposition! Hosted in Seattle, Washington, USA at the Washington State Convention Center, this highly scientific event will bring together an international audience of over 1,200 from 55 countries. A dynamic program committee headed by the renowned Kinam Park, promises you cutting-edge research, opportunities to “Thinking Outside the Box" Delivery Technologies: Nanocarriers from Nature,” make meaningful connections, and more.
For more information and to register, please visit the CRS website here.
We look forward to seeing you in July!
Thu21Jul2016Fri22Jul201610:00AM EST; 1:00PM ESTOnline Webinar
Considerations for Choosing a Pre-Clinical Model of Wet Age-Related Macular Degeneration
Each webinar session will be 30-minutes, including a brief Q&A session.
In this intriguing webinar Dr. Sweigard will cover:
- An overview of the VEGF induced and laser CNV models
- Timing for therapeutic intervention in each model
- Alternative model selection
- Species selection
About The Presenter
J. Harry Sweigard, PhD
Principal Scientist , Absorption
Dr. Harry Sweigard is a Principal Scientist in the Ophthalmology unit at Absorption Systems in San Diego California. Prior to joining Absorption Systems he was a lab head at Novartis Institutes for Biomedical Research where he studied the underlying mechanisms of ocular inflammation. During his postdoctoral training and as an instructor at Massachusetts Eye and Ear Infirmary/Harvard Medical School he used a diverse set of rodent models of vascular retinopathy to better understand innate immune system involvement in retinal vascular homeostasis. This work led to several peer-reviewed articles including a recent publication in Science Translational Medicine. This was a natural segue from his doctoral work at Tufts Sackler School where he designed novel viral vectors aimed at dampening innate immune system activation towards therapies for age-related macular degeneration.
Dr Sweigard applies his extensive experience and expertise in ocular and neurodegenerative disease modeling to develop and validate in vivo models at Absorption Systems that can be used to determine efficacy, distribution and safety of novel ocular therapies and delivery systems.
Mon01Aug2016Wed03Aug2016University of Rhode Island College of Pharmacy in Kingston, Rhode Island
Absorption Systmes is delighted to sponsor The University of Rhode Island College of Pharmacy 4th Annual Transporters in Drug Discovery and Development: Driving Knowledge from Laboratory to Label (TDDD 2016), an intensive three-day training course in drug transport to be held August 1-3, 2016 at the University of Rhode Island College of Pharmacy in Kingston, Rhode Island. Due to generous sponsorship, limited fellowships that cover registration are available to trainees and industry scientists. Please email Dr. Angela Slitt (email@example.com) to inquire.
This high level hands-on course delivers current knowledge about drug transporters with industry and FDA perspectives. TDDD2016 is presented by expert instructors in the evolving area of transporters and their impact on drug disposition and absorption. We are pleased that our program will feature an FDA expert speaker and have hands on training sessions.
Fore more information and to register, please visit: http://web.uri.edu/pharmacy/cpd/drugtransporters/
Thu15Sep2016Fri16Sep2016Hilton Rockville Hotel & Executive Meeting Center, Rockville, Md.
The first GBHI Conference took place in March 2015 in Amsterdam, The Netherlands. This conference was a very successful one due to the active contributions of key regulatory scientists from EMA and the U.S. Food and Drug Administration, as well as other regulatory agencies.
For more information and to register, please visit the AAPS Website.
Fri16Sep2016San Diego - Country Inn & Suites
Join Absorption Systems on Friday, September 16th at the CACO-PBSS San Diego event.
Topic: "DMPK and Toxicology Considerations for Preclinical Development of Biologics"
For more information and to register for this event, please visit: http://www.pbss.org/aspx/homesd.aspx
Thu29Sep20168:00am - 12:00pmDoubleTree Hotel | Somerset, New Jersey
Complex drug products comprise a growing pharmaceutical sector, due to the safety, efficacy, and compliance benefits they provide. As reflected in recent regulatory science initiatives by the Food and Drug Administration (FDA), there is a rising interest in enhancing access to alternate and interchangeable versions available for all CDP categories by applying a rational, science-driven approach that conceptually relies on quality by design. During this symposium, we will discuss the evolving approaches for guiding formulation development, predicting in vivo performance, establishing critical manufacturing variables, and enhancing equivalence assurance of complex drug products. As an application of biopharmaceutics in the current pharmaceutical landscape, we will also review the expanding utility of BCS based biowaivers.
For more information and to register, please visit: http://www.genericsand505b2.com/
Purchase your tickets today! Click Here to Register
Mon03Oct2016Courtyard by Marriott Boston Cambridge (Cambridge, MA)
Please join Absorption Systems, Monday, October 3, 2016 in Boston!
"Physiologically Based Pharmacokinetic Modeling (PBPK) in Drug Discovery and Development: Industry Examples and Regulatory Perspective"
For more information and to register, please visit: https://www.pbss.org/aspx/homeBoston.aspx
Wed05Oct2016Fri07Oct2016La Jolla, CA
Absorption Systems will be attending this year's Meeting on the Mesa, please contact us if you would like to meet with one of our representatives: firstname.lastname@example.org
- 800+ attendees over the course of the three-day conference
- 700+ one-on-one meetings scheduled throughout the Partnering Forum using an online system to connect attendees
- 70+ speakers and panelists covering topics from market access to the latest discoveries in gene editing
- 60+ presentations by the field’s most prominent publicly traded and emerging private companies
- 5+ scientific posters highlighting cutting-edge research from labs throughout the country on display
- 10+ interactive panels addressing critical commercial, scientific, regulatory and reimbursement issues
- Zero reasons to miss the 2016 meeting!
For more information and to register, please visit: http://www.meetingonthemesa.com/
Join Absorption Systems at the New Jersey Drug Metabolism Discussion Group, October 13, 2016.
For more information and to register, please visit the NJDMDG website: http://www.njacs.org/topical-groups/drug-metabolism
Mon17Oct2016Wed19Oct2016Minneapolis Convention Center (Minneapolis, MN)
Visit Absorption Systems as we exhibit at the 2016 AdvaMed Conference in Minneapolis this coming October.
AdvaMed 2016 is the leading MedTech Conference in North America, bringing more than 1,000 companies together in a uniquely multifaceted environment for business development, capital formation, innovative technology showcasing, world-class educational opportunities and networking. An event rich in international flavor and featuring a deep, diverse attendee list that includes influential policy-makers, business executives and media, AdvaMed 2016 seeks to advance industry discussion from key perspectives through detailed panel sessions, executive forums and more. It is a “must-attend” event for any medtech company. Whatever your goals may be, you are sure to accomplish, and even surpass them, at AdvaMed 2016.
For more information and to register for this event, please visit the AdvaMed website: http://advamed2016.com/
Advances and applications in Dissolution Science
Join Absorption Systems at DISSO-Europe 2016, an international conference dedicated to the Science of Dissolution, organised by Society for Pharmaceutical Dissolution Science (India) and the Romanian Academy of Sciences with the participation of worldwide recognised specialist groups. Hanson Research and ABL&E shall have a common booth and we shall be glad to welcome you and give information on the latest developments in this field.
Our Director of Operations, Vatsala Naageshwaran will be speaking On Day 1 (October 20th), "Roadmap To Approval: Enabling BCS based biowaivers for immediate release oral dosage products"
For more information on this event, please visit: http://www.ablelab.eu/news/disso-europe-2016
Visit Absorption Systems' Booth at the ISSX Workshop in Boston. We would love the opportunity to meet with you while we will be onsite for a couple days!
The ISSX Workshop on Human Pharmacokinetic Predictions on October 27-28, 2016 will deliver state-of-the-art science in a focused meeting. Key sessions will include:
- Gap analyses in human PK/clearance prediction at drug discovery and development stages
- Methodological aspects of clearance prediction for low clearance and highly bound compounds
- Predicting clearance mediated by non-CYP metabolizing enzymes
- Quantitative assessment of hepatobiliary transporter- mediated clearance
- Human PK/clearance prediction in special populations
For more information and to register please visit the ISSX Website.
Wed09Nov2016Sat12Nov2016University of Kansas
The Globalization of Pharmaceutics Education Network (GPEN) Executive Committee and the Department of Pharmaceutical Chemistry at The University of Kansas, are pleased to announce the 11th biennial GPEN conference in Lawrence, Kansas. Attendance by invitation only.
Wed09Nov201612:30 pmResearch Triangle Park, NC
Absorption Systems will be represented at this year's RTP Drug Metabolism Discussion Group Fall Dinner Meeting, if you would like to speak to one of our representatives at this event, please contact us today.
2016 Fall Dinner Meeting: Drug Transporters and Statin Therapy: Clinical Relevance and Real-World Patient Care.
For more information or to register for this event, please visit: http://www.rtpdmdg.org/events/
Sat12Nov2016Sun13Nov2016Colorado Convention Center, Denver
A workshop that examines the challenges with establishing bioequivalence of locally acting topical, ocular, and inhalation pharmaceutical products and which presents various relevant solutions that could form the basis of best practice approaches for evaluating the bioequivalence of such products.
Held in conjunction with the 2016 AAPS Annual Meeting and Exposition.
The demonstration of bioequivalence for locally acting drugs, for which the site of action is at or near the site of application and upstream from the systemic circulation, has frequently posed some of the greatest challenges in bioequivalence. Historically, extremely expensive clinical endpoint bioequivalence studies have generally been the centerpiece of bioequivalence assessments for such products. In addition to the high cost and difficulty associated with such clinical endpoint studies, they are notoriously insensitive toward formulation differences. Although these problems have plagued those firms seeking to develop a variety of different dosage forms, three of the most problematic routes of administration have been topical (dermatological), ocular, and inhalation. The vast majority of publications and public meetings addressing bioequivalence for products administered via these three routes have focused narrowly on a single route of administration. However, there are many challenges that are common to the development of alternative bioequivalence strategies of products administered via these three non-oral routes.
This workshop seeks to bring together the latest research and thinking from these three fields to explore the possibilities of developing more unified, totality of evidence-based approaches toward the demonstration of bioequivalence for these products in ways that significantly reduce the clinical burden.
Who Should Attend
This workshop will be of particular interest to scientists in preclinical and clinical development, interested in branded and generic small molecule therapeutic drug products. Particularly relevant for small to medium size companies who are trying to enter the space of locally acting drug products.
Tue15Nov201610:00 AM – 12:00 NoonColorado Convention Center - Room 205
The primary purpose of this session is to understand and quantify the functional parameters that control product performance to establish bioequivalence for locally acting drug products. Measures of functional performance include permeation across relevant biological barriers; drug accumulation at the site of action and its distribution in adjacent tissues; and potential biomarker quantitation that directly correlate to its pharmacologic effect. Combining traditional structural characterization of locally acting formulations with orthogonal functional measures of effect augments the case for a possible bio-exemption and has the potential to be applicable across broader product categories.
Add to your AAPS Calendar Today: https://annual.aapsmeeting.org/event/member/272599
Fri18Nov20168:00 amDoylestown, PA
Join Absorption Systems as we sponsor this year's Annual Regional Biotech Conference at the Pennsylvania Biotechnology Center in Bucks County. Contact Us Today to Request an Onsite Meeting.
Save the Date!
Regional Biotech 2016 Annual Meeting
FRIDAY NOVEMBER 18, 2016, 2:00PM - 5:00PM
NETWORKING RECEPTION 5:00-6:00
PA Biotechnology Center: 3805 Old Easton Road, Doylestown, PA 18902
Mon05Dec2016Courtyard by Marriott Boston Cambridge
Biotherapeutic products are the fastest growing medicines in the pharmaceutical market. Despite their clinical success, the immunogenicity of biotherapeutics continues to be a major concern. Assessment of immunogenicity as well as appropriate interpretation of immunogenicity data is therefore, of critical importance for defining safety profile and it is one of the regulatory requirements for the approval of these products. In the past decade, much progress has been made towards how immunogenicity should be studied. At this workshop, experts from industry, academia and former FDA will provide an overview of the methods used for assessing immunogenicity of biotherapeutics, case studies as well as current challenges and the most important considerations in interpreting results in the context of regulatory review of these products.
The following topics will be presented with ample opportunity for discussion:
- Regulatory perspective on immunogenicity assessment strategies and methodologies
- Immunogenicity risk assessment and mitigation strategies
- Considerations for anti-drug and neutralizing method design, development and validation
- Immunogenicity of novel therapeutic modalities
- Overcoming challenges in immunogenicity testing
- Immune tolerance induction: basic concepts and case studies
Register Today - Click Here
Visit Absorption Systems Table to Meet with one of our Scientific Experts!
Wed07Dec20165:30 pmCambridge, MA
Thu08Dec201612:00 PM - 6:00 PMCambridge, MA
Now in its 5th year, the MassBio CRO/CMO Symposium draws more than 300 attendees to discuss and evaluate the best practices that have evolved in shortening time to market. Through a series of panel discussions and breakout roundtables, we will evaluate the strategies that have evolved in outsourcing and strategic partnerships in pre-clinical, clinical and manufacturing.
Event will be held at the Boston Marriott Cambridge Hotel (50 Broadway, Cambridge, MA 02142)
For more information or to register for this event, please visit the MassBio Website.